(68Ga)pentixafor
Showing 1 - 25 of 1,836
Thymoma Trial in Beijing (68Ga-Pentixafor)
Recruiting
- Thymoma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023
Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)
Recruiting
- Multiple Myeloma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 3, 2022
Positron-Emission Tomography Trial in Fuzhou (68Ga-Pentixafor)
Recruiting
- Positron-Emission Tomography
- 68Ga-Pentixafor
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 27, 2022
68Ga-Pentixafor PET/CT for Subtyping Diagnosis of Primary
Completed
- Primary Aldosteronism
- 68Ga-Pentixafor PET/CT imaging
-
Chongqing, Chongqing, ChinaThe First Affilated Hospital of Chongqing Medical University
Jul 13, 2022
Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)
Recruiting
- Non-Hodgkin Lymphoma
- Multiple Myeloma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 4, 2022
Neuroendocrine Tumors Trial in Iowa City ([68Ga]Pentixafor)
Recruiting
- Neuroendocrine Tumors
-
Iowa City, IowaHolden Comprehensive Cancer Center
Mar 16, 2022
Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)
Not yet recruiting
- Marginal Zone Lymphoma
- (no location specified)
Nov 6, 2023
Acute Cellular Graft Rejection, Cardiac Sarcoidosis, Myocarditis Due to Drug Trial in Lausanne ([68Ga]Ga-PentixaFor PET/CT)
Not yet recruiting
- Acute Cellular Graft Rejection
- +2 more
- [68Ga]Ga-PentixaFor PET/CT
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois
Aug 11, 2022
CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)
Not yet recruiting
- CXCR4
- +2 more
- 68Ga-pentixafor
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 15, 2022
Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)
Recruiting
- Lymphoma
- +2 more
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 6, 2021
Aldosterone-Producing Adenoma Trial (CXCR4)
Not yet recruiting
- Aldosterone-Producing Adenoma
- CXCR4
- (no location specified)
Apr 20, 2023
Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)
Recruiting
- Prostate Cancer
- PET/CT
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of China University of Science and
Jul 19, 2023
Adrenal Mass Trial in Peking (Gallium-68 Pentixafor PET/CT)
Unknown status
- Adrenal Mass
- Gallium-68 Pentixafor PET/CT
-
Peking, ChinaPeking Union Medical College Hospital
Apr 22, 2021
Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)
Recruiting
- Prostate Cancer
-
Nanjing, Jiangsu, China68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023
Tumor Positron-Emission Tomography Trial in Fuzhou (68Ga-DOTATATE and 68Ga-FAPI)
Recruiting
- Tumor Positron-Emission Tomography
- 68Ga-DOTATATE and 68Ga-FAPI
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 7, 2023
Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)
Recruiting
- Neuroendocrine Tumors
- Al18F-NOTA-LM3
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 20, 2023
Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis Trial in Xiamen (Drug: 68Ga-FAPI)
Recruiting
- Spondyloarthritis
- +2 more
- Drug: 68Ga-FAPI
-
Xiamen, Fujian, ChinaThe first affiliated hospital of Xiamen University
Aug 13, 2023
Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)
Recruiting
- Bladder Cancer
- [68Ga]-NOTA-SGC8
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 14, 2023
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy
Recruiting
- Primary Myelofibrosis
- 68Ga FAPI PET/CT
-
Xiamen, Fujian, ChinaBing Xu
Nov 28, 2023
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Myositis, Idiopathic Inflammatory Myopathies Trial in Xiamen (68Ga-FAPI)
Recruiting
- Myositis
- Idiopathic Inflammatory Myopathies
-
Xiamen, Fujian, ChinaThe first affiliated hospital of Xiamen University
Jul 12, 2023
Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)
Recruiting
- Hepatocellular Carcinoma
- [68Ga]Ga-NOTA-RG2 PET Imaging
-
Shanghai, ChinaHuashan Hospital
Nov 19, 2023